Disseminated bartonellosis in a child with steroid-dependent nephrotic syndrome receiving mycophenolate mofetil monotherapy - 11/05/21
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Highlights |
• | Mycophenolate mofetil is considered as a safe treatment with low infectious risk. |
• | Disseminated bartonellosis may occur under mycophenolate mofetil monotherapy. |
• | Patients receiving mycophenolate mofetil should be cautious with cat contacts. |
Abstract |
Cat scratch disease, usually a benign infectious disease, may develop as multisystem disease with multiorgan involvement, particularly in immunocompromised patients. We report on a patient who developed disseminated bartonellosis while receiving mycophenolate mofetil monotherapy treating steroid-dependent nephrotic syndrome, highlighting that severe infection can be observed in those patients. Therefore, this category of patients should be cautious when having contact with kittens and receives proper prevention advice.
Le texte complet de cet article est disponible en PDF.Keywords : Bartonellosis, Mycophenolate mofetil, Steroid-dependent nephrotic syndrome
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?